Common TitleELECTRON (Arms 12-17 and 22)
Official Title Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside inhibitor GS-9669 Against HCV Genotype 1 Infection.
Phase Phase II
ClinicalTrials.gov NCT01260350
Treatments
Ledipasvir-Sofosbuvir

Ledipasvir-Sofosbuvir
Tradename:HarvoniOther Names:LDV-SOFClass:FDA-ApprovedFunding
IndustryGilead Sciences